253 related articles for article (PubMed ID: 23707487)
1. ARF1 controls Rac1 signaling to regulate migration of MDA-MB-231 invasive breast cancer cells.
Lewis-Saravalli S; Campbell S; Claing A
Cell Signal; 2013 Sep; 25(9):1813-9. PubMed ID: 23707487
[TBL] [Abstract][Full Text] [Related]
2. ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions.
Schlienger S; Ramirez RA; Claing A
Cell Signal; 2015 Mar; 27(3):403-15. PubMed ID: 25530216
[TBL] [Abstract][Full Text] [Related]
3. ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein.
Boulay PL; Schlienger S; Lewis-Saravalli S; Vitale N; Ferbeyre G; Claing A
Oncogene; 2011 Sep; 30(36):3846-61. PubMed ID: 21478909
[TBL] [Abstract][Full Text] [Related]
4. Activation of H-Ras and Rac1 correlates with epidermal growth factor-induced invasion in Hs578T and MDA-MB-231 breast carcinoma cells.
Koh MS; Moon A
Biochem Biophys Res Commun; 2011 Mar; 406(1):25-9. PubMed ID: 21281602
[TBL] [Abstract][Full Text] [Related]
5. The adaptor proteins p66Shc and Grb2 regulate the activation of the GTPases ARF1 and ARF6 in invasive breast cancer cells.
Haines E; Saucier C; Claing A
J Biol Chem; 2014 Feb; 289(9):5687-703. PubMed ID: 24407288
[TBL] [Abstract][Full Text] [Related]
6. ARF6 promotes the formation of Rac1 and WAVE-dependent ventral F-actin rosettes in breast cancer cells in response to epidermal growth factor.
Marchesin V; Montagnac G; Chavrier P
PLoS One; 2015; 10(3):e0121747. PubMed ID: 25799492
[TBL] [Abstract][Full Text] [Related]
7. Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase.
Zuo Y; Shields SK; Chakraborty C
Biochem Biophys Res Commun; 2006 Dec; 351(2):361-7. PubMed ID: 17064663
[TBL] [Abstract][Full Text] [Related]
8. Studies of the roles of ADP-ribosylation factors and phospholipase D in phorbol ester-induced membrane ruffling.
Hiroyama M; Exton JH
J Cell Physiol; 2005 Feb; 202(2):608-22. PubMed ID: 15389577
[TBL] [Abstract][Full Text] [Related]
9. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
10. ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells.
Boulay PL; Cotton M; Melançon P; Claing A
J Biol Chem; 2008 Dec; 283(52):36425-34. PubMed ID: 18990689
[TBL] [Abstract][Full Text] [Related]
11. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
[TBL] [Abstract][Full Text] [Related]
12. Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1.
Xie X; Tang SC; Cai Y; Pi W; Deng L; Wu G; Chavanieu A; Teng Y
Oncotarget; 2016 Sep; 7(36):58111-58120. PubMed ID: 27517156
[TBL] [Abstract][Full Text] [Related]
13. ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion.
Schlienger S; Campbell S; Claing A
Mol Biol Cell; 2014 Jan; 25(1):17-29. PubMed ID: 24196838
[TBL] [Abstract][Full Text] [Related]
14. ARF1 recruits RAC1 to leading edge in neutrophil chemotaxis.
Mazaki Y; Onodera Y; Higashi T; Horinouchi T; Oikawa T; Sabe H
Cell Commun Signal; 2017 Oct; 15(1):36. PubMed ID: 28969640
[TBL] [Abstract][Full Text] [Related]
15. Assays and properties of arfaptin 2 binding to Rac1 and ADP-ribosylation factors (Arfs).
Shin OH; Exton JH
Methods Enzymol; 2005; 404():359-67. PubMed ID: 16413282
[TBL] [Abstract][Full Text] [Related]
16. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
17. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
[TBL] [Abstract][Full Text] [Related]
18. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
[TBL] [Abstract][Full Text] [Related]
19. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
Yang C; Klein EA; Assoian RK; Kazanietz MG
Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
[TBL] [Abstract][Full Text] [Related]
20. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells.
Zhu Y; Shen T; Liu J; Zheng J; Zhang Y; Xu R; Sun C; Du J; Chen Y; Gu L
Cell Signal; 2013 May; 25(5):1075-85. PubMed ID: 23353182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
